<html>
<head>PUBMED IDs for SLC22A17</head>
<body bgcolor='#C5F0F2'><h1>SLC22A17</h1><a href='https://pubmed.ncbi.nlm.nih.gov/21950422/'>Lipocalin-2 is associated with modulation of disease phenotype in a patient with concurrent JAK2-V617F and BCR-ABL mutation.</a> March 10  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/25468909/'>Estrogen receptor (ER)Î±-regulated lipocalin 2 expression in adipose tissue links obesity with breast cancer progression.</a> May 12  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26230641/'>Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in children.</a> June 16  2015<br></body></html>
